IDYA
Price
$18.82
Change
-$0.33 (-1.72%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
1.64B
81 days until earnings call
TCRX
Price
$1.37
Change
-$0.07 (-4.86%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
81.49M
82 days until earnings call
Interact to see
Advertisement

IDYA vs TCRX

Header iconIDYA vs TCRX Comparison
Open Charts IDYA vs TCRXBanner chart's image
IDEAYA Biosciences
Price$18.82
Change-$0.33 (-1.72%)
Volume$14.87K
Capitalization1.64B
TScan Therapeutics
Price$1.37
Change-$0.07 (-4.86%)
Volume$23.02K
Capitalization81.49M
IDYA vs TCRX Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. TCRX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (IDYA: $19.15 vs. TCRX: $1.44)
Brand notoriety: IDYA and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 0% vs. TCRX: 174%
Market capitalization -- IDYA: $1.64B vs. TCRX: $81.49M
IDYA [@Biotechnology] is valued at $1.64B. TCRX’s [@Biotechnology] market capitalization is $81.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 6 TA indicator(s) are bullish while TCRX’s TA Score has 6 bullish TA indicator(s).

  • IDYA’s TA Score: 6 bullish, 4 bearish.
  • TCRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both IDYA and TCRX are a good buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а +10.63% price change this week, while TCRX (@Biotechnology) price change was +9.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.64B) has a higher market cap than TCRX($81.5M). IDYA YTD gains are higher at: -25.486 vs. TCRX (-52.632). TCRX has higher annual earnings (EBITDA): -124.58M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. TCRX (252M). IDYA has less debt than TCRX: IDYA (26M) vs TCRX (97M). IDYA has higher revenues than TCRX: IDYA (7M) vs TCRX (4.42M).
IDYATCRXIDYA / TCRX
Capitalization1.64B81.5M2,007%
EBITDA-356.46M-124.58M286%
Gain YTD-25.486-52.63248%
P/E RatioN/AN/A-
Revenue7M4.42M158%
Total Cash693M252M275%
Total Debt26M97M27%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
44
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYATCRX
RSI
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BPLEX9.67N/A
N/A
Boston Partners Long/Short Equity Inv
MPGVX15.21N/A
N/A
Mondrian Global Equity Value
MWOCX47.74N/A
N/A
MFS Global Growth C
NDVSX16.51N/A
N/A
MFS New Discovery Value R2
PAEIX14.32N/A
N/A
T. Rowe Price Overseas Stock Advisor

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
N/A
IMNM - IDYA
58%
Loosely correlated
+6.82%
RCKT - IDYA
58%
Loosely correlated
N/A
CGON - IDYA
57%
Loosely correlated
-1.75%
NTLA - IDYA
57%
Loosely correlated
+2.83%
CRNX - IDYA
56%
Loosely correlated
+0.53%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with IMNM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+9.09%
IMNM - TCRX
46%
Loosely correlated
+6.82%
FATE - TCRX
45%
Loosely correlated
+2.56%
IDYA - TCRX
43%
Loosely correlated
N/A
SYRE - TCRX
43%
Loosely correlated
+1.96%
STRO - TCRX
42%
Loosely correlated
+7.67%
More